Two Weeks of CFM!

9:42 PM

Author | Sara Walker

After finishing our first three sequences of M2 year, my classmates and I were treated to two full weeks of CFM (Clinical Foundations of Medicine). It's amazing to realize how far we've come, as everyone had to perform a full history and physical exam (H&P) in one hour during each of the two weeks.

Conversely, in my Medical Spanish class where all the other students are M1s, we read through a passage outlining the cardiac physical exam, and I was the only one who understood why certain maneuvers were performed.

After our one hour of attempting the H&P (and "attempt" is definitely the proper word – most of us were scrambling to finish), we next had to write up the patient encounter and present it to our attending (CFM instructor). Despite the fact that I felt like I was bumbling through most of the physical, the experience was incredibly helpful, and I improved from the first week to the second. My main issue is remembering which physical exam maneuver to perform next and how to do so in the most efficient manner. As with everything, I suppose the best thing to improve is to practice.

During these two weeks, we also participated in two electives, designed to broaden our medical horizons. For example, I attended "Video Production for Physicians" and "Leadership Communication." Other options included exposure to medical writing, optimal work-life balance, and the role of osteomyelitis in the Battle of Gettysburg (for the budding orthopedic surgeon).

As my usual study methods involve streaming and minimal lecture attendance, I don't see my classmates quite as often and certainly not en masse. Consequently, the sudden barrage of germs caused my immune system to go haywire with a lovely cold. Or, URI (upper respiratory infection) as I am apparently supposed to say now.

Nevertheless, these past two weeks were a welcome respite from stuffing interminable amounts of information into my brain. I got to enjoy the fall colors, the perfect temperature (right around 60°F), and even got a caramel apple from Kilwin's!

CFM has now come to a close, and we started our next sequence yesterday – Psychiatry. Seems like a fitting topic for Halloween, no?

© Copyright 1995-2024 Regents of the University of Michigan
Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories headshot of Carrie Ferrario
Department News
ORTDD career development spotlight featuring Dr. Carrie Ferrario
ORTDD career development spotlight featuring Dr. Carrie Ferrario
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
IUD 101
IUDs are becoming one of the most popular forms of birth control for all ages. In this episode, we cover a recent Health Lab article Q&A on IUDs with Dr. Monica Rosen of University of Michigan Health.
man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
surgical area of clinicians drawn out with blue background
Health Lab
New tools that leverage NIH’s ‘All of Us’ dataset could improve anesthesia and surgical care
In a report in JAMA Surgery, researchers propose two novel tools that leverage the All of Us dataset to look at acute health events such as surgery.
Dr. Adina Turcu
Department News
Internal Medicine Faculty Spotlight − Dr. Adina Turcu
Adina Turcu, MD, MS is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes, dedicated to providing comprehensive and compassionate care to her patients.
prescription pad drawn
Health Lab
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.